Technical Analysis for EARS - Auris Medical Holding AG

Grade Last Price % Change Price Change
grade F 2.89 -7.37% -0.23
EARS closed down 7.37 percent on Monday, May 20, 2019, on 1.62 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: May 21

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical EARS trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Reversal New Lows Setup Bearish Swing Setup 0.00%
New 52 Week Low Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -7.37%

Older signals for EARS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical trials for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss, as well as for Meniere diseases; and other development programs comprising AM-102 and AM-123 that are in preclinical studies. It has a collaboration and license agreement with Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, and drug delivery devices and formulations for the treatment of inner ear disorders. The company was formerly known as Auris Medical AG and changed its name to Auris Medical Holding AG in April 2014. Auris Medical Holding AG was founded in 1998 and is headquartered in Zug, Switzerland.
Biopharmaceutical Pharmaceutical Products Drug Delivery Nervous System Perception Hearing Loss Drug Delivery Devices Ear Hearing Tinnitus
Is EARS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 39.4
52 Week Low 2.78
Average Volume 162,755
200-Day Moving Average 8.6242
50-Day Moving Average 6.1202
20-Day Moving Average 4.8097
10-Day Moving Average 3.994
Average True Range 0.7525
ADX 24.72
+DI 13.0116
-DI 22.849
Chandelier Exit (Long, 3 ATRs ) 4.3405
Chandelier Exit (Short, 3 ATRs ) 5.0375
Upper Bollinger Band 7.0231
Lower Bollinger Band 2.5963
Percent B (%b) 0.07
BandWidth 92.039005
MACD Line -0.8767
MACD Signal Line -0.7053
MACD Histogram -0.1715
Fundamentals Value
Market Cap 128.11 Million
Num Shares 44.3 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -3.85
Price-to-Sales 0.00
Price-to-Book 6.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.85
Resistance 3 (R3) 3.92 3.67 3.69
Resistance 2 (R2) 3.67 3.43 3.64 3.64
Resistance 1 (R1) 3.28 3.27 3.16 3.21 3.58
Pivot Point 3.03 3.03 2.97 3.00 3.03
Support 1 (S1) 2.64 2.79 2.52 2.57 2.20
Support 2 (S2) 2.39 2.63 2.36 2.14
Support 3 (S3) 2.00 2.39 2.09
Support 4 (S4) 1.93